University College London – IoN

Institute of Neurology

Organization

UCL is Europe’s research powerhouse in neuroscience. We are ranked second in the world, and first in Europe, in neuroscience and behaviour by Thomson ISI Essential Science Indicators. UCL Neuroscience brings together over 400 investigators and provides one of the best international environments to educate and train the next generation of research leaders and attract the best students.

The Institute of Neurology is a specialist postgraduate institute of UCL. It is closely associated in its work with the National Hospital for Neurology & Neurosurgery, University College London Hospitals’ NHS Foundation Trust, and in combination they form a national and international centre at Queen Square for teaching, training and research in neurology and allied clinical and basic neurosciences.

The Institute of Neurology is a key component of the newly formed Faculty of Brain Sciences at UCL, and has eight academic Departments.   These encompass clinical and basic research within each theme:

  • Brain Repair and Rehabilitation – Professor Xavier Golay
  • Clinical and Experimental Epilepsy – Professor Matthew Walker
  • Clinical Neurosciences, Royal Free campus – Professor Tony Schapira
  • Imaging Neuroscience – Professor Ray Dolan
  • Molecular Neuroscience, incorporating the Reta Lila Weston Institute of Neurological Studies – Professor John Hardy
  • Motor Neuroscience and Movement Disorders – Professor Linda Greensmith & Neurodegenerative Disease – Professor John Collinge
  • Neuroinflammation (Professor Ken Smith)

Role within Neuromics

Lead for Huntington’s disease, site PI for UCL-ION HD; WP3 leader, involved in WP4

Related projects

Please see all details on the 3 websites below for full up to date details and publications:

Workpackage involvement

  • Workpackage 1 - Deep phenotype analysis in pre-symptomatic and symptomatic NDD/NMD patients
  • Workpackage 3 - Identification of modifying factors in cohorts enriched by deep phenotyping
  • Workpackage 4 - Identification of hypothesis-driven biomarkers for disease progression